SphK1/S1P signaling network: From molecular mechanism to therapeutic targeting
Life Sciences · 2026-12 · 406 · 124752
DOI: 10.1016/j.lfs.2026.124752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2026-12. Verfasst von Duxiao Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical and Basic Medicine, Shandong First Medical University, Jinan, 250014, China; Science and Technology Innovation Center, Shandong Fi…. Hauptthemen laut MEDLINE: Phosphotransferases (Alcohol Group Acceptor), Sphingosine, Signal Transduction, Lysophospholipids. Die Arbeit nennt 141 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Sphingosine kinase 1 (SphK1) is a key rate-limiting enzyme in the sphingolipid metabolic network. It generates sphingosine-1-phosphate (S1P) by catalyzing the phosphorylation of Sphingosine (Sph). It plays a key regulatory role in various physiological and pathological processes such as cell proliferation, survival, migration, inflammatory response and immune regulation. SphK1 closely connects intracellular lipid metabolism with extracellular GPCR signaling network, forming a complex "inside-out" signal transduction system. In this review, we focus on the current understanding of SphK1, including its structure characteristics, activation mechanism and signal transduction pathway. We also review the roles of SphK1 pathway in tumor, inflammation and immunity, cardiovascular, nervous system, digestive system, respiratory system and metabolic disease. Establishing a correlation between SphK1 or the SphK1/S1P signal axis and targeted drugs such as inhibitors, agonists, even some natural Chinese medicines, provides important theoretical support for understanding the potential of SphK1 as a therapeutic target. Finally, we propose future research directions based on current advances and shortcomings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical and Basic Medicine, Shandong First Medical University, Jinan, 250014, China; Science and Technology Innovation Center, Shandong First Medical University, Jinan, 250014, China. Electronic address: yang…
- Department of Human Anatomy, Shandong University School of Medicine, Jinan, 250012, China. Electronic address: wzhen@sdu.edu.cn.
Förderung
- Shandong Province Natural Science Foundation
Zitieren
APA
Yang, D., & Wang, Z. (2026). SphK1/S1P signaling network: From molecular mechanism to therapeutic targeting. Life Sciences, 406, 124752. https://doi.org/10.1016/j.lfs.2026.124752
Vancouver
Yang D, Wang Z. SphK1/S1P signaling network: From molecular mechanism to therapeutic targeting. Life Sciences. 2026;406:124752. doi:10.1016/j.lfs.2026.124752
BibTeX
@article{Yang2026,
author = {Yang, Duxiao and Wang, Zhen},
title = {SphK1/S1P signaling network: From molecular mechanism to therapeutic targeting},
journal = {Life Sciences},
year = {2026},
volume = {406},
pages = {124752},
doi = {10.1016/j.lfs.2026.124752}
}
EUVIMED